- Home
- ASND vs WBS Comparison
ASND vs WBS Comparison
Compare ASND & WBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- WBS
- Stock Information
- Founded
- ASND 2006
- WBS 1935
- Country
- ASND Denmark
- WBS United States
- Employees
- ASND N/A
- WBS N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- WBS Major Banks
- Sector
- ASND Health Care
- WBS Finance
- Exchange
- ASND Nasdaq
- WBS Nasdaq
- Market Cap
- ASND 10.6B
- WBS 9.7B
- IPO Year
- ASND 2015
- WBS N/A
- Fundamental
- Price
- ASND $195.58
- WBS $61.52
- Analyst Decision
- ASND Strong Buy
- WBS Buy
- Analyst Count
- ASND 16
- WBS 15
- Target Price
- ASND $240.75
- WBS $68.07
- AVG Volume (30 Days)
- ASND 418.2K
- WBS 1.1M
- Earning Date
- ASND 11-13-2025
- WBS 10-16-2025
- Dividend Yield
- ASND N/A
- WBS 2.60%
- EPS Growth
- ASND N/A
- WBS 6.88
- EPS
- ASND N/A
- WBS 4.92
- Revenue
- ASND $576,332,355.00
- WBS $2,486,236,000.00
- Revenue This Year
- ASND $101.37
- WBS $7.07
- Revenue Next Year
- ASND $76.17
- WBS $4.85
- P/E Ratio
- ASND N/A
- WBS $12.51
- Revenue Growth
- ASND 54.50
- WBS 2.60
- 52 Week Low
- ASND $111.09
- WBS $39.43
- 52 Week High
- ASND $208.16
- WBS $63.99
- Technical
- Relative Strength Index (RSI)
- ASND 52.37
- WBS 56.26
- Support Level
- ASND $196.06
- WBS $61.14
- Resistance Level
- ASND $202.57
- WBS $62.43
- Average True Range (ATR)
- ASND 6.49
- WBS 1.19
- MACD
- ASND -0.82
- WBS -0.11
- Stochastic Oscillator
- ASND 34.34
- WBS 28.45
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About WBS Webster Financial Corporation
Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania. The company's segment includes Commercial Banking, HSA Bank, and Consumer Banking. It generates maximum revenue from the Commercial Banking segment.